FinTechFunding

Atomo Diagnostics: Receives TGA approval for COVID-19 test

  • The approval means that medical professionals in Australia can now use the company’s COVID-19 blood test, AtomoRapid
  • The product will now added to Atomo’s Australian Register of Therapeutic Goods (ARTG) listing, with the HIV Self-Test
  • AtomoRapid jointly manufactured by Atomo and a French company, NG Biotech
  • NG manufactures the test strip, while Atomo manufactures the device
  • Atomo co-founder and Managing Director, John Kelly, pleased with the approval
  • Atomo is up 8.82 per cent on the market this morning and is trading for 37 cents per share
Previous article
SECOS Group: Signs supply contract for pet waste bags
Next article
Trigg Mining: Receives encouraging SOP results from Lake Throssell
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

IG Group Considers Switching Listing from London to New York

The financial services firm explores a potential move to enhance visibility.Highlights: IG Group is weighing a move from...
FinTech

Huawei and Yowpay Launch Open Banking Smartwatch POS App

Innovative app combines open banking with smartwatch technology for payments.Highlights: Huawei partners with Yowpay to introduce a smartwatch...
FinTech

UK Banks Reject Opportunity to Lift £100 Contactless Limit

Major UK banks choose not to increase contactless payment thresholds.Highlights: UK banks will not raise the £100 contactless...
FinTech

Crypto.com Cuts 12% of Workforce Amid AI Shift

The company streamlines operations in response to evolving market dynamics.Highlights: Crypto.com reduces workforce by 12%Focus shifts to AI...